Catalyst Wire Dossier Catalyst Wire Dossier

Esbriet

pirfenidone · Roche/Genentech
Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for Esbriet, covering 2012-01-26 to 2026-07-10. Get the full timeline:

Most recent: EMA Authorised: Esbriet (Pirfenidone) — H.A.C. Pharma

See pricing